找化学品上960化工网!
960化工网

替卡格雷 | 274693-27-5

替卡格雷
Ticagrelor
274693-27-5
C23H28F2N6O4S
522.5680
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:替卡格雷结构式
9871419
替卡格雷价格
简介
Ticagrelor (AZD6140) 是可逆的,具有口服活性的 P2Y12 受体拮抗剂,可用来研究血小板聚集。
名称和标识符
MDL MFCD09954148
InChIKey OEKWJQXRCDYSHL-FNOIDJSQSA-N
Inchi 1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
SMILES S(C([H])([H])C([H])([H])C([H])([H])[H])C1N=C2C(=C(N=1)N([H])[C@]1([H])C([H])([H])[C@@]1([H])C1C([H])=C([H])C(=C(C=1[H])F)F)N=NN2[C@]1([H])C([H])([H])[C@@]([H])([C@]([H])([C@@]1([H])O[H])O[H])OC([H])([H])C([H])([H])O[H]
别名信息
- 中文别名 -
  • 替卡格雷
  • 替卡格雷杂质
  • 阿索卡诺
  • 硫秋水仙苷
  • 替格瑞洛
  • 替格瑞洛单晶、依折麦布单晶、利伐沙班单晶、索非布韦单晶
  • 替卡格雷(Anticogulant)
  • 替卡格雷标准品
  • 替卡格雷标准品及杂质
  • 替卡格雷及其中间体
  • 替卡格雷药
  • 替卡格雷杂质及标准品
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-二氟苯基)环丙基]氨基]-5-丙硫基三唑并[4,5-d]嘧啶-3-基]-5-(2-羟乙氧基)-1,2-环戊二醇
  • (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-二氟苯)环丙基]氨基}-5-(丙基硫氧嘧啶)-3H-[1,2,3]-三唑磷[4,5-D]嘧啶-3-基]-5-(2-羟乙基)环戊烷-1,2-二醇
  • 提卡格雷
  • 替格瑞洛杂质81
  • 替格瑞洛杂质81摩科品牌 生产自制274693-27-5
- 英文别名 -
  • Ticagrelor
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
  • (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • AR-C 126532XX
  • AZD 6140
  • AZD-6140
  • Brilinta
  • Brilique
  • TICARGRELOR
  • Ticagrelor Impurity 81
  • (1S,2S,3R,5S)-3-(7-(((1R,2S)
  • AZD6140
  • [14C]-Ticagrelor
  • GLH0314RVC
  • C23H28F2N6O4S
  • (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • (1S,2S,3R,5S)
  • A850981
  • J-524969
  • Ticagrelor (Brilinta,AZD6140)
  • s4079
  • TICAGRELOR (USP-RS)
  • J-016772
  • Ticagrelor Form
  • TICAGRELOR [EMA EPAR]
  • TICAGRELOR [EP MONOGRAPH]
  • compound 17 [PMID: 17827008]
  • (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)aMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • NCGC00379052-01
  • DTXSID901009337
  • 1,2-Cyclopentanediol, 3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-D1,2-Cyclopentanediolifluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
  • AR-C 126532XX
  • AZD6140
  • CHEBI:68558
  • Ticagrelor- Bio-X
  • EX-A503
  • BDBM50397205
  • CHEMBL398435
  • TICAGRELOR [JAN]
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[5,4-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • ticagrelorum
  • (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfanyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • AR-C126532XX
  • AR-C126532
  • HSDB 8306
  • AS-19943
  • Ticagrelor [USAN:INN:BAN]
  • OEKWJQXRCDYSHL-FNOIDJSQSA-N
  • (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2 diol
  • (1s,2s,3r,5s)-3-[7-[[(1r,2s)-2-(3,4-difluorophenyl)-cyclopropyl]amino]-5-(propylthio)-3h-[1,2,3]-triazolo[4,5-d]pyrimidine-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol
  • NCGC00379052-02
  • TICAGRELOR [MART.]
  • Z2235802088
  • HY-10064
  • B01AC24
  • (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • DTXCID501436166
  • TICAGRELOR [MI]
  • TICAGRELOR [USP-RS]
  • CS-0619
  • AKOS015900739
  • AM85693
  • EN300-19659674
  • TICAGRELOR [INN]
  • NS00098771
  • D09017
  • TICAGRELOR (MART.)
  • Ticagrelor [USAN]
  • SCHEMBL1979652
  • TICAGRELOR (EP MONOGRAPH)
  • 1,2-Cyclopentanediol,3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-,(1S,2S,3R,5S)-
  • compound 17 (PMID: 17827008)
  • Brilinta (TN)
  • (1S,2S,3R,5S)-3-(7-(((1R)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • MFCD09954148
  • AB01565855_02
  • (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy) cyclopentane-1,2-diol
  • 274693-27-5
  • Ticagrelor (JAN/USAN/INN)
  • EX-6274
  • TICAGRELOR [VANDF]
  • (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPYL]AMINO]-5-(PROPYLTHIO)-3H-1,2,3-TRIAZOLO[4,5-D]PYRIMIDIN-3-YL]-5-(2-HYDROXYETHOXY)-1,2-CYCLOPENTANEDIOL
  • TICAGRELOR [ORANGE BOOK]
  • TICAGRELOR [WHO-DD]
  • BT164470
  • CCG-269870
  • UNII-GLH0314RVC
  • Possia
  • GTPL1765
  • Q420542
  • AC-24755
  • (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)- 3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • DB08816
  • (1S,2S,3R,5S)-3-(7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
  • HMS3885B03
物化性质
实验特性
LogP 2.08670
PSA 163.74000
折射率 1.74
沸点 777.551°C at 760 mmHg
熔点 149-154 °C
闪点 45°C(Lit.)
溶解度 DMSO 105 mg/mL Water <1 mg/mL Ethanol 53 mg/mL
密度 1.67
计算特性
精确分子量 522.18600
氢键供体数量 4
氢键受体数量 12
可旋转化学键数量 10
同位素质量 522.18608089g/mol
重原子数量 36
复杂度 736
同位素原子数量 0
确定原子立构中心数量 6
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 2
互变异构体数量 4
表面电荷 0
拓扑分子极性表面积 164
海关数据
海关编码 2933990090
海关数据

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

生产方法和用途
用途 原料药,用于减少急性冠脉综合征(ACS)患者的心血管死亡和心脏病发作。
专业数据库参考
PubChemId 9871419
参考资料
Reaxys RN
化合物详情(旧版)

替卡格雷物理化学性质

沸 点:777.551 °C at 760 mmHg
折 射 率:1.744
闪 光 点:424.048 °C
密 度:1.67
 

产品用途



应用领域



化学品安全说明书(MSDS)



储运特性





替卡格雷推荐生产厂家
960化工网为您提供替卡格雷专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:274693-27-5,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:274693-27-5
平台客服 平台客服

平台在线客服